Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on listing of Deutsche Bank’s exchange traded funds on NASDAQ OMX Stockholm
Mandate

Vinge advises on listing of Deutsche Bank’s exchange traded funds on NASDAQ OMX Stockholm

April 20, 2010

Vinge has advised Deutsche Bank in connection with the listing of db x-trackers, Deutsche Bank’s trading platform for exchange traded funds (“ETFs”) on NASDAQ OMX Stockholm. Up to now, 21 ETFs have been listed and are currently being traded on NASDAQ OMX Stockholm.

Vinge also advised during the negotiations with Euroclear Sweden AB regarding clearing and settlement for db x-trackers EFTs prior to trading on NASDAQ OMX Stockholm.

Vinge’s team consisted of Fredrik Wilkens (responsible partner), Ola Sandersson (partner), Dan Hanqvist (clearing and settlement), Maria Schultzberg (tax issues), Emma Stuart-Beck (project manager), Katarina Rykowska, Katarina Rodell and Ulrica Åkesson.

 

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

 Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026